These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 16079985

  • 21. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J, Muller EW, van Goor H, Weening JJ, Elema JD.
    Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM, Sharon Z, Pauli BU, Lewis EJ.
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [Abstract] [Full Text] [Related]

  • 23. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD, Bertram JF, Ryan GB.
    Exp Nephrol; 1995 Dec; 3(5):270-9. PubMed ID: 7583048
    [Abstract] [Full Text] [Related]

  • 24. Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger.
    Shimizu S, Saito M, Kinoshita Y, Kazuyama E, Tamamura M, Satoh I, Satoh K.
    BJU Int; 2009 Sep; 104(5):713-7. PubMed ID: 19338546
    [Abstract] [Full Text] [Related]

  • 25. The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats.
    Trachtman H, Zavilowitz B, Bennett B, Goldsmith DI.
    Pediatr Res; 1985 Aug; 19(8):828-34. PubMed ID: 3898001
    [Abstract] [Full Text] [Related]

  • 26. Cathepsin B and L in nephron segments of rats with puromycin aminonucleoside nephrosis.
    Olbricht CJ, Cannon JK, Tisher CC.
    Kidney Int; 1987 Sep; 32(3):354-61. PubMed ID: 3669494
    [Abstract] [Full Text] [Related]

  • 27. Increased glomerular and urinary malondialdehyde in puromycin aminonucleoside-induced proteinuria in rats.
    Srivastava RN, Diven S, Kalia A, Travis LB, Ansari NH.
    Pediatr Nephrol; 1995 Feb; 9(1):48-51. PubMed ID: 7742222
    [Abstract] [Full Text] [Related]

  • 28. Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria.
    Thakur V, Walker PD, Shah SV.
    Kidney Int; 1988 Oct; 34(4):494-9. PubMed ID: 2848972
    [Abstract] [Full Text] [Related]

  • 29. Effect of grape seed extract on puromycin-aminonucleoside-induced nephrosis in rats.
    Mattoo TK, Kovacevic L.
    Pediatr Nephrol; 2003 Sep; 18(9):872-7. PubMed ID: 12836089
    [Abstract] [Full Text] [Related]

  • 30. Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms.
    Hattori T, Ito M, Suzuki Y.
    Jpn J Pharmacol; 1991 Aug; 56(4):465-73. PubMed ID: 1744988
    [Abstract] [Full Text] [Related]

  • 31. Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat.
    Kimura K, Endou H, Sakai F.
    J Toxicol Sci; 1979 Feb; 4(1):1-10. PubMed ID: 480401
    [Abstract] [Full Text] [Related]

  • 32. Identification by an EPR technique of decreased mitochondrial reducing activity in puromycin aminonucleoside-induced nephrosis.
    Ueda A, Nagase S, Yokoyama H, Tada M, Ohya H, Kamada H, Hirayama A, Koyama A.
    Free Radic Biol Med; 2002 Oct 15; 33(8):1082-8. PubMed ID: 12374619
    [Abstract] [Full Text] [Related]

  • 33. Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats.
    Yatsu T, Aoki M, Tanaka A.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):121-6. PubMed ID: 15740732
    [Abstract] [Full Text] [Related]

  • 34. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR, Karnovsky MJ.
    J Lab Clin Med; 1987 May 07; 109(5):538-44. PubMed ID: 3572200
    [Abstract] [Full Text] [Related]

  • 35. Effect of the in vivo catalase inhibition on aminonucleoside nephrosis.
    Pedraza-Chaverri J, Granados-Silvestre MD, Medina-Campos ON, Hernández-Pando R.
    Free Radic Biol Med; 1999 Aug 07; 27(3-4):245-53. PubMed ID: 10468195
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
    Magil A.
    J Am Soc Nephrol; 1996 Nov 07; 7(11):2340-7. PubMed ID: 8959623
    [Abstract] [Full Text] [Related]

  • 37. Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside.
    Shibasaki T, Matsuda H, Gomi H, Usui M, Ishimoto F, Sakai O.
    Am J Nephrol; 1996 Nov 07; 16(2):167-72. PubMed ID: 8919236
    [Abstract] [Full Text] [Related]

  • 38. Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin aminonucleoside nephrosis.
    Shiiki H, Sasaki Y, Nishino T, Kimura T, Kurioka H, Fujimoto S, Dohi K.
    Pathobiology; 1998 Nov 07; 66(5):221-9. PubMed ID: 9732237
    [Abstract] [Full Text] [Related]

  • 39. Effect of albumin administration on L-tryptophan levels in the serum and tissues of rats with puromycin aminonucleoside-induced nephrosis.
    Sasaki E, Ohta Y, Ishiguro I.
    Adv Exp Med Biol; 1999 Nov 07; 467():341-6. PubMed ID: 10721075
    [Abstract] [Full Text] [Related]

  • 40. Tryptophan-niacin metabolism in rat with puromycin aminonucleoside-induced nephrosis.
    Egashira Y, Nagaki S, Sanada H.
    Int J Vitam Nutr Res; 2006 Jan 07; 76(1):28-33. PubMed ID: 16711654
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.